chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative: Hives/blisters after second dose of Pfizer. These developed 1 week after the second dose. Per pt it started at the site of vaccination and then extended to entire body including scalp, perineum, torso. There was blistering. He went to local ED. He received Pfizer vaccine at Pharmacy where he is pharmacy tech Pt went to local ED and was given PO steroids, steroids topical. Specific dates of vaccination, date of reaction, and treatment medication name/dose unknown.
pt recvd vax;w/in 15 mins of vax became unresponsive;resp & cardiac systems stable;this lasted approx 5mins then became more responsive then just lethargic;hypotonic rxn to pertussis;
Before vaccinating patient she reported that she had warm feeling and itching after receiving first vaccine for Covid.  She was total she should premedicate with Benadryl before arriving for her second vaccine.  She reported that she forgot to take it and I offered that she come back on a day when she had premedicated.  Patient stated, "I am here and I don't want to come back.  Just give me the vaccine.  5 minutes after receiving vaccine, patient reported itching.  Medicated with Benadryl 25 mg po.  Vital sign:  BP 133/52, HR 84, RR 16 and pulse ox 95%.  Within 10 minutes of receiving Benadryl patient states that her symptoms were resolved.  At discharge, BP 152/ 68, HR 92, RR 18 and Pulse ox 99%.  Patient discharged with family member
Information has been received from a doctor of pharmacy (Pharm. D) concerning a 29 year old female patient inpatient at psychiatric hospital with asthma, depression and no drug reactions and allergies who on 19-MAY-2010 at 9:46 A.M. was vaccinated SQ with a dose of PNEUMOVAX 23 (dose not reported; lot number 664535/0060Z). Concomitant therapy included DEPAKOTE and "nicotine patch". At 17:30 P.M. on that same day, the patient developed fever of 101.2 F and arthralgias. She went to the emergency room where they gave her TYLENOL and ULTRAM. Then she was made inpatient at the hospital (a different campus than the 1st hospital) where she received AVELOX, TORADOL, BENADRYL, vancomycin and SOLU-MEDROL. The following laboratories were performed: CBC, urinalysis, basic metabolic profile (results not provided). The patient was getting worse and she also was unable to partake in the psychiatric programs at the 1st hospital due to this event. At the time of reporting, the patient had not recovered from the events. Pharmacist considered fever of 101.2 f and arthralgias were considered to be disabling and an other important medical event. Additional information has been requested.
A week after the Moderna Booster, I had a full body rash from my neck to my waist.   After a day, it started to spread down my legs as well to my knees.
Inconsolable crying for 3 days after getting 1st set of vaccines at physician's office.
At the vaccination day only soreness at the injection site. I started feeling bad on 12/27/20 with a sore throat. Monday I had a bit of sinus congestion and Tuesday 12/29/20 no sense of smell or taste. I was tested that day on 12/29/20 and was positive.
Dermatographia all over body; This spontaneous case was reported by a consumer and describes the occurrence of MECHANICAL URTICARIA (Dermatographia all over body) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced MECHANICAL URTICARIA (Dermatographia all over body). At the time of the report, MECHANICAL URTICARIA (Dermatographia all over body) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. No concomitant medication was provided.
Heavy onset of period began that day. Since the final shot of GARDASIL, patient menstruates heavily every 9 to 12 days with a heavy 5 day cycle. Very small break in between periods. Patient is anemic.
bleeding from lt leg inj site x 2 days;mom states would stop bleeding, then start w/movement of leg;states stoppable w/pressure;no longer bleeding;no hematoma to site;
Client felt dizzy and nauseated after around 10 min of vaccine administration. Blood pressure taken, patient laid down for 15 min and started feeling better, set down for about 10 min and said she was feeling well enough to stand and leave.
Sore injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore injection site). At the time of the report, VACCINATION SITE PAIN (Sore injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was provided.  The patient doesn't had email or fax.   Most recent FOLLOW-UP information incorporated above includes: On 10-Mar-2021: Follow up information was received on 7-May-2021 and contains no new information.
REDNESS, SWELLING AT INJECTION SITE, ACHES, CHILLS NO FEVER, REDNESS EXTENDS TO 5.5 CM TODAY 10/20/2010
Sudden hearing loss shortly after booster shot. Took Prednisone several times to relieve symptoms. It helped, but symptoms have been recurring. Ringing in ears, and occasional roaring sound
Vaccine exposure during pregnancy; aches; chills; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), PAIN (aches) and CHILLS (chills) in a 31-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (compazine), Asthma since 1994 and Hypertension (has improved recently) since 2016.   On 13-Jan-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 13-Aug-2020 and the estimated date of delivery was 20-May-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), PAIN (aches) and CHILLS (chills). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved and PAIN (aches) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Sep-2020, Pregnancy test: positive (Positive) positive. On 12-Dec-2020, Ultrasound scan: normal (normal) Normal. On 30-Dec-2020, Ultrasound scan: normal (normal) normal.         No concomitant medications were reported. Treatment details were not provided. Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-010749 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow up received and contains No New Information.
3 days after receiving MMR/VARIVAX pt. experienced febrile seizure lasting 1.5 min. No illness, viral or otherwise found at ER evaluation.
36 hours after shot: left armpit started with small intermittent burning pain. 48 hours after: burning pain intermittent but moderate. 60 hours: Burning pain small at level of 3-4, sharp burning pains intermittently, started using ice and tylenol. 72 hours: Burning pain constant at 4-6; sharp pains intermittent - felt like being burned with cigarette at level 7-8; using ice and tylenol. Had telehealth visit and was advised to start motrin and topical voltaren. 84 hours: Constant moderate burning pain, intermittent sharp burning pains 8-10; Took a total of 1800MG of Motrin and 2000MG of Tylenol, topical voltaren twice and ice with no relief, went to Emergency room. Was prescribed Prednisone 60MG daily for 5 days, Gabapentin for pain and antibiotics for possible infection
Activity change, fatigue, congestion, loss of smell, loss of taste, cough, SOB, diarrhea, and weakness.
Moderna COVID-19 VaccineS Headache Weakness in legs, arm Aching all over But no g eyes, stuffy nose 36 hour total duration
A patient received a partial dose of FLUZONE QUADRIVALENT HIGH DOSE due to the vaccine leaking no AE; vaccine leaking out from between the needle and the connection tip on the syringe no AE; Initial information regarding an unsolicited valid non-serious case was received from a pharmacist via a consumer/non-health care professional via Medical Information  (Reference number- 00829551) and transmitted to Sanofi on 26-Oct-2021 a specific country.  This case involves a 66 year old female patient who had received a partial dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] due to the vaccine leaking from between the needle and the connection tip on the syringe (underdose and syringe issue).  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.  The patient had no concomitant vaccination.   On 26-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ709AA, expiry: 30-Jun-2022, formulation: prefilled syringe) via intramuscular route in the left arm for prophylactic vaccination.  It was a case of an actual medication due to Underdose and Syringe leak (latency same day).  It was reported "Pharmacist says that while a technician was administering a dose of FLUZONE high dose (HD) some of the medication leaked around the needle. Caller wants to know if they need to re-administer the medication to the patient. A Pharmacist reporting on behalf of a consumer getting a partial dose of FLUZONE QUADRIVALENT HIGH DOSE due to the vaccine leaking out from between the needle and the connection tip on the syringe. Pharmacist reported that the consumer may have received half of the dose."  No other adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
can not put weight on it; pain right hip; pain right knee; This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT BEARING DIFFICULTY (can not put weight on it), ARTHRALGIA (pain right hip) and ARTHRALGIA (pain right knee) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced ARTHRALGIA (pain right hip) and ARTHRALGIA (pain right knee). On 24-Mar-2021, the patient experienced WEIGHT BEARING DIFFICULTY (can not put weight on it). At the time of the report, WEIGHT BEARING DIFFICULTY (can not put weight on it), ARTHRALGIA (pain right hip) and ARTHRALGIA (pain right knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was provided. Patient called to report that he had his first Moderna vaccine on 17Mar21 in the left arm. He states that on the 20Mar21 he started experiencing joint pain only in the right knee and hip he can barely move and can not seem to put weight on it today 24Mar21. History of diabetes. He gives consent to be contacted
Started with lump in right ancillary, painful and swollen, saw Dr., sent me for ultrasound. Results of ultrasound were received I was sent to a local health care center, performed further imaging and mammogram. After mammogram recommended for biopsy to determine what it was. Biopsy results came back benign, indicated as inflammation in lymph nodes due to Covid vaccine.
Patient got Covid; Initial information was received on 14-Dec-2020 regarding an unsolicited valid non-serious case received from a consumer (patient) via social media.  This case involved an unknown age patient who patient got Covid (corona virus disease) (COVID-19), after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.   On an unknown date, it was reported that patient got Covid (corona virus disease) (COVID-19), unknown latency following the administration of INFLUENZA VACCINE.   Laboratory test included COVID-19 test.   It was not reported if the patient received a corrective treatment.   At the time of reporting, the outcome was unknown for the reported event.   There would be no information available on batch number for this case.
shingles; Information has been received from a lawyer, regarding a case in litigation, and refers to an approximately 68-year-old female patient (pt) who was also 68-years-old at the time of vaccination. No information about the pt's medical history, concurrent conditions and concomitant medications was provided. On or about 19-SEP-2011, the pt was administered zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) at a pharmacy for the long-term prevention of shingles and zoster-related conditions. As a result of her receipt of zoster vaccine live (ZOSTAVAX), the pt was caused to suffer shingles on or about 03-OCT-2011, including any and all of its sequelae (also reported as subsequently (date not provided), the pt was treated by a healthcare provider for shingles, resulting from the pt's use of zoster vaccine live (ZOSTAVAX)). As a direct and proximate result of zoster vaccine live (ZOSTAVAX) manufacturing defect, the pt suffered severe and permanent physical injuries, including but not limited to shingles, as well as other severe and permanent health consequences (also reported as had been caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages). The pt had endured substantial pain and suffering. She had incurred significant expenses for medical care and treatment, and would continue to incur such expenses in the future. The pt had lost earnings and had suffered a loss of earning capacity. The pt had suffered and would continue to suffer economic loss, and had otherwise been physically, emotionally and economically injured. The pt's injuries and damages were permanent and would continue into the future. The outcome of the event was considered to be not recovered. The reported considered the event of shingles to be related to zoster vaccine live (ZOSTAVAX).  The event of shingles was considered to be disabling.
Rash with swelling; warm to the touch; red with a distinct line of rash; Rash with swelling; This is a spontaneous report from a contactable consumer (patient herself). A 29-years-old female patient non- pregnant received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN6205), dose 1 via an unspecified route of administration, administered in Arm Left on 04Mar2021 at 14:30 (at the age of 29-years-old) as a DOSE 1, SINGLE for covid-19 immunisation at Public Health Clinic/Veterans Administration facility. The patient medical history included herpes virus infection and asthma both from an unknown date and unknown if ongoing. Other medications in two weeks were Birth control medications. The patient did not have any known allergies. Other vaccine in four weeks were none. Patient did not have covid prior vaccination was not tested for covid post vaccination. On 11Mar2021 at 20:00, patient experienced rash with swelling, warm to the touch and red with a distinct line of rash. No treatment was received for the events. Outcome of all the events were not recovered.  No follow-up attempt is possible. No further information expected.
Swelling, tenderness, erythema of right upper arm.  Mother reports the swelling and redness has improved.  7 cm x 6 cm of induration, mild erythema noted.  Treated with Keflex 250mg qid for 7 days.
Client contacted agency in PM of 01/29/2004 and reported urticaria developing at 16:30.  Took Benadryl spoke with MD, no other s/s.  Seen by MD 01/30/04 and diagnosed probable allergy to antibiotic Avelox (started AM 01/29/04).
pt recvd vax; pt exp lip edema & taken to hosp; tx w/ benadryl; pt devel also hives following vax;
coughing excessively,mucous from mouth, extreme ear and head pain, swollen lymph nodes, difficult open mouth all the way.
Fever, chills, fatigue, headache, nausea, pain in arm, aches throughout body
facial droop, tongue numbness, ear and facial pain, arm weakness, blurred vision and difficulty swallowing and chewing.
About a few hours after getting the vaccine, my arm was in so much pain that it felt broken along with 102 fever, headache, nausea, diarrhea, and body aches. About 2 days later, I looked in the mirror and I noticed my mouth was drooping on the right side and weakness in my right hand. I went to the Emergency Room and was diagnosed with Bell's Palsy. At this time the symptoms have lessened but I still have some weakness on the right side.
Rash up and down whole arm; Rash over arms Itching really bad; This spontaneous case was reported by a consumer and describes the occurrence of   in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Neuropathy (Neuropathy) and Arthritis (Arthritis.). Concurrent medical conditions included Diabetes (Diabetes) and Allergy (Seasonal allergies). Concomitant products included PIPERAZINE CITRATE (CITRAZINE), LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOMER [LEVOCETIRIZINE DIHYDROCHLORIDE]), VITAMIN 15 and GABAPENTIN for an unknown indication.    On 06-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Laboratory details were not provided.  Treatment information was provided as cortisone.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
pt recv vax & started w/runny nose-next day eyes all red, sneezing, rash on bottom & front of body, lips dry, itchy;adenoids inflamed w/swelling behind them;
Septic shock; AKI; Respiratory Destress; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old male patient received bnt162b2 (BNT162B2), administered in arm, administration date 19Mar2021 (Lot number: ER8737) at the age of 60 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetic" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing); "Neuropathy" (unspecified if ongoing); "allergies" (unspecified if ongoing), notes: Known allergies: Yes. No COVID prior vaccination. The patient took concomitant medications. No other vaccine in four weeks. There are other medications in two weeks. The following information was reported: SEPTIC SHOCK (hospitalization, medically significant, life threatening) with onset 20Mar2021, outcome "recovered with sequelae", described as "Septic shock"; ACUTE KIDNEY INJURY (hospitalization, medically significant, life threatening) with onset 20Mar2021, outcome "recovered with sequelae", described as "AKI"; RESPIRATORY DISORDER (hospitalization, life threatening) with onset 20Mar2021, outcome "recovered with sequelae", described as "Respiratory Destress". The patient was hospitalized for septic shock, acute kidney injury, respiratory disorder (hospitalization duration: 28 day(s)). Therapeutic measures were taken as a result of septic shock, acute kidney injury, respiratory disorder, reported as many treatment. No COVID tested post vaccination.
Information has been received from a physician concerning a female patient with a history of syncope who was vaccinated with the first dose of Gardasil. Concomitant therapy included hepatitis A vaccine (inactive) (MSD). Subsequently, the patient experienced syncope and twitching and was hospitalized to rule out seizures. The length of the hospital stay was not specified. On an unspecified date, the patient recovered from syncope and twitching. It was also reported that the patient did not have this experience with the second dose of Gardasil. Additional information has been requested.
PT FAINTED AFTER RECEIVING 5 VACCINES: (HPV#1; HAV#2 - RT DELTOID) AND (IPV, MENACTRA, AND TDAP - LT DELTOID).  PT SAID RT ARM WAS TINGLING PRIOR TO HER PASSING OUT.  PT WAS UNRESPONSIVE FOR APPROX. ONE MINUTE AND ONE EPISODE OF VOMITING AFTER REGAINING CONSCIOUSNESS.
Woke up at 4:00 AM with a fever of a 101.5, chills, body aches, nausea, dizziness, and extreme fatigue. I was too tired to get out of the bed. Later in the morning, I took two Ibuprofen (400 mg.) which helped reduce the severity of symptoms after a couple of hours. Felt like influenza without the respiratory symptoms. This was my second dosage; the first dosage I had last Spring, and had a similar experience but was not as severe as this one. I was unable to go into work today because of my symptoms.
It started with a little bit of a sore throat and the body aches came on Tuesday. That lasted until about Thursday. On Wednesday, I took a COVID-19 test, but it was negative. On Thursday, my mother was having symptoms. She took a COVID-19 test and was positive. I retested and was positive. On Friday morning, I called the doctor. Based on my symptoms and because I have Lupus, they suggested I start antivirals that day. Saturday, it felt more like a cold. I had congestion, drainage, and sneezing. By Sunday and today, I feel better. I'm just tired.
Received Moderna vaccines on 2/18/21, 3/18/21 Positive for COVID by PCR on 7/29/21 known exposure to COVID; symptom onset 7/25/21 w/ myalgia, fever, cough, congestion
1 week after administration, patient developed red, itching rash with pain in middle of back and under arms. patient did not develop any blistering. patient say her family physician and was diagnosed with shingles but was not treated with medication. physician wanted to watch patient and ride out the adverse reaction. 2 weeks after administration on 8/14/20, patient developed enlarged lymph node under her left arm. physician still did not treat and wanted patient to ride out reaction. patient said md was to report adverse reaction but wanted pharmacy to report also.
L arm 2x2 in erythema edema and pruritic sx. 5/10/09.